Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
3(21%)
Results Posted
10%(1 trials)

Phase Distribution

Ph phase_3
1
7%
Ph phase_4
1
7%
Ph not_applicable
10
71%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(10)

Detailed Status

Completed10
Recruiting2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 31 (7.7%)
Phase 41 (7.7%)
N/A10 (76.9%)

Trials by Status

not_yet_recruiting17%
active_not_recruiting17%
completed1071%
recruiting214%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14